Legislation Quick Search
09/25/2021 09:37 PM
Pennsylvania State Senate
https://www.legis.state.pa.us/cfdocs/Legis/CSM/showMemoPublic.cfm?chamber=S&SPick=20170&cosponId=22630
Share:
Home / Senate Co-Sponsorship Memoranda

Senate Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications
NEW!

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search


Senate of Pennsylvania
Session of 2017 - 2018 Regular Session

MEMORANDUM

Posted: January 31, 2017 10:36 AM
From: Senator John C. Rafferty, Jr.
To: All Senate members
Subject: Official State Prescription Form
 
I will be re-introducing legislation, SB 472, specifically targeting the growing problem of prescription drug diversion and prescription drug abuse.

My new legislation for this session expands the requirements contained in former legislation. Along with Schedule II drugs, Schedule III and Schedule IV drugs would also be required to be prescribed using an official state prescription form. Legitimately approved Schedule II, III, and IV controlled substances such as Oxycodone, Hydrocodone, certain amphetamines, and various benzodiazepines, are becoming more readily available to unintended users through various methods of diversion. The use and demand for these drugs continues to rise making these drugs not only more dangerous but also more lucrative for those wishing to profit from their sale. Increased demand for prescription narcotics has pushed street prices for drugs such as Oxycodone as high as $30 per tablet. The criminal activity associated with illicitly obtaining and distributing these drugs, as well as serious consequences of illicit use, including addiction and fatal overdose deaths, are becoming more common throughout the Commonwealth.

Along with combating the growing problem of diversion, this legislation would also address another issue which contributes to the loss of millions of dollars a year to the Commonwealth. Medicaid fraud has become increasingly more common and contributes to the illegal prescription drug market. By utilizing tamper proof prescription pads with built-in security protections, the Commonwealth would be able to significantly curtail fraudulent Medicaid claims and save millions of dollars. In fact, A New York law requiring doctors to use tamperproof, official state prescription for all written prescriptions generated $60 million in Medicaid fraud savings in the first six months of accounting oversight.

This legislation would establish an official state prescription form for distribution by the Secretary of Health for use by medical professionals authorized to prescribe drugs. These forms will be serially numbered and non-transferable and would be required for use by a medical professional when prescribing any Schedule II, III or IV prescription drug. The Secretary of Health would also be granted the authority over directing the proper retention and filing of such prescription forms and would require the immediate notification of the Department of Health and the Attorney General’s Office in the event that such forms are lost or stolen from a healthcare provider.



Introduced as SB640